Roadblocks for omega 3 as AstraZeneca and Acasti Pharma both report failed trials

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

Hofseth Biocare (HBC) has received a new dietary ingredient (NDI) status from the US Food and Drug Administration (FDA) for its CalGo and OmeGo products. 

FormattedPicture

NUTRITION & HEALTH NEWS

A nutritional supplement with an added omega 3 fatty acid can improve cognition in severely malnourished children, according to a US study which says the findings can... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Norway-based Aker BioMarine will now be able to enforce its patent related to the production and composition of krill oil, following a decision by the European Patent... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Ultra-processed food (UPF) consumption is on the rise, particularly among the 60-plus demographic, according to a new study. This is especially concerning in light of... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

US-based ingredients supplier Ingredients by Nature (IBN) is partnering with alfalfa (Medicago sativa) specialist Virentia in preparation for launching a new chloroplast... Read More

trans